• Home
  • Category
  • Non invasive Intracranial Pressure Monitoring Devices Market

Non-invasive Intracranial Pressure Monitoring Devices Market Size, Share, & Trends Analysis Report By Type (MRI/CT, TMD), By Application (Traumatic Brain Injury, Meningitis), By Region, And Segment Forecasts,

Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: chemicals | Format: Report available in PDF / Excel Format

View Details Buy Now 2999 Download Sample Ask for Discount Request Customization

Market Size & Trends

The size of the global non-invasive intracranial pressure monitoring devices market was USD 350.9 million in 2024 and is expected to grow at a CAGR of 5.2% during the period from 2025 to 2030. The increasing prevalence of neurological disorders and rising road accidents, which lead to traumatic brain injuries, are some of the major factors driving the market growth. Furthermore, the introduction of new technologies, increasing need for minimally invasive procedures, and the high rate of demand for these devices in trauma care are some other factors driving the market growth. The growing incidents of neurological illnesses, including intracranial tumors, hydrocephalus, aneurysms, infection in the brain, and meningitis, coupled with the surging number of trauma events brought on by traffic accidents, falls, and sport-related injuries, are expected to propel market expansion.

A major study published in The Lancet Neurology in 2021 found that more than 3 billion people globally were living with a neurological condition, based on evidence from the World Health Organization (WHO) and the Global Burden of Disease Study. Neurological disorders have become the leading cause of ill health and disability globally, with Disability-adjusted Life Years (DALYs) rising by 18% since 1990. This growing prevalence of neurological conditions drives the demand for the non-invasive intracranial pressure monitoring devices industry to help manage and monitor these conditions more effectively.

As per the American Association for the Surgery of Trauma, road injuries resulted in about 1.2 million fatalities worldwide in 2017, leading to higher Intracranial Pressure (ICP) and propelling the demand for ICP monitoring devices. Furthermore, brain infections like meningitis, which infect cerebrospinal fluid and elevate ICP, also fuel the market expansion. The WHO has estimated about 30,000 meningitis cases every year in sub-Saharan Africa. ICP monitoring devices are required for real-time pressure monitoring, allowing early disease detection and timely intervention by neurosurgeons, thus increasing the demand for these devices.

1 in 161 people born today is projected to develop brain or nervous system cancer in their lifetime. An estimated 308,000 new cases of brain and nervous system cancer arise worldwide every year, causing more than 251,000 deaths. The rising incidence of these disorders fuels the need for sophisticated diagnostic equipment. In addition, MRI/CT scans are the most popularly used imaging equipment due to their enhanced sensitivity in evaluating abnormal ICP in head injury patients.

These nations, including the U.S. and Canada, have experienced a high rate of occurrence of neurological conditions and trauma victims. For example, as per the report released by the American Association for the Surgery of Trauma in 2020, one of the top causes of death in the U.S. for patients up to the age of 45 is trauma. Besides, the availability of technologically equipped healthcare facilities and the growing awareness among patients about the advantages involved in minimally invasive procedures are some of the key drivers influencing market growth. In addition, an increase in the incidence of road accidents is expected to increase the demand for intracranial pressure monitoring devices. For example, as per the report by the Brain Injury Association of Waterloo-Wellington (BIAWW), more than 11,000 people lose their lives from brain-related injuries in Canada annually and over 6,000 are left permanently disabled after injuries. This is expected to drive market growth during the forecast period.

In addition, the world's geriatric population is growing at a rapid rate. As per the UN Department of Economic and Social Affairs, the world's population is currently 7.7 billion and is projected to grow to 9.7 billion by 2050. The geriatric population is susceptible to different neurological disorders as well as traumatic brain injury. Therefore, the growing geriatric population across the globe is anticipated to be a high-impact driver for the market throughout the forecast period. Additionally, the high geriatric population in countries in Asia, including Japan and China, provides various untapped opportunities, hence driving the growth of the market throughout the forecast period. According to estimates, over 20% of Japan's population is above 65 years of age. Fall-related injuries among the elderly are one of the major health and social issues in China, with a reported 18% to 44% of elderly individuals falling, as noted in a WHO report.

Report Coverage & Deliverables

PDF report & online dashboard will help you understand

  • Competitive benchmarking
  • Historical data & forecasts
  • Company revenue shares
  • Regional opportunities
  • Latest trends & dynamics

Type Insights

The MRI/CT segment dominated the non-invasive intracranial pressure monitoring device industry, accounting for the largest revenue share of 28.4% in 2024. These devices help to get results faster and safely, and they are easy to use and provide excellent images with high contrast between pathologic and normal tissues. Moreover, MRI/CT scans are the widely preferred imaging devices owing to their higher sensitivity to assess patients with traumatic brain injuries with elevated ICPs. Thus, increasing applications in the diagnosis and staging of neurological diseases, as well as their advantages over other imaging modalities, have fueled the growth of this segment.

The optic nerve sheath diameter segment is expected to grow at the fastest CAGR of 5.7% over the forecast period. It is the most appropriate and widely preferred modality for emergency medical situations, such as severe head trauma, hydrocephalus, and intracranial hemorrhage. The increasing prevalence of elevated ICP from neurological and systemic disorders is driving the demand for non-invasive ICP monitoring. Early detection is vital for improved outcomes. Ultrasound measurement of Optic Nerve Sheath Diameter (US-ONSD) provides a fast, safe, and non-invasive method for real-time ICP assessment, correlating with papilledema.

Application Insights

The traumatic brain injury segment dominated the non-invasive intracranial pressure monitoring devices industry with the largest revenue share in 2024. Traumatic Brain Injury (TBI) affects over 54 to 60 million people annually, often resulting in hospitalization or death. TBI is among the leading causes of mortality and permanent disability. The Global Burden of Disease Study 2016 reported 27.08 million new TBI cases, with falls being the primary cause. Road Traffic Accidents (RTAs), violence, sports injuries, and work-related accidents also contribute to TBI. This high incidence of TBI, which requires effective monitoring and early intervention, drives the demand for non-invasive intracranial pressure monitoring devices for safer, real-time management of patients.

The intracerebral hemorrhage segment in the non-invasive intracranial pressure monitoring device industry is expected to grow at a significant CAGR over the forecast period. Intracerebral Hemorrhage (ICH) remains a major global health issue, contributing significantly to mortality and disability. The GBD 2021 study identified stroke as the third-leading cause of death, responsible for 7.3 million deaths (10.7% of all deaths), and the fourth-leading cause of DALYs, accounting for 160.5 million DALYs (5.6% of total DALYs). ICH represents 28.8% of all stroke incidents, making it a substantial part of the overall stroke burden. This high prevalence and the critical nature of ICH cases drive the demand for non-invasive intracranial pressure monitoring devices to effectively manage and monitor patients at risk of elevated ICP.

The other segment, which includes brain edema, hydrocephalus, and CNS infection, is expected to grow rapidly in the coming years. Brain edema results in elevated intracranial pressure, which involves precise measurement for early and effective treatment. Therefore, a major portion of the global population is suffering from CNS infection, hydrocephalus, or brain edema, which depends on ICP measurement for timely and safe treatment of such conditions.

Regional Insights

Market Analysis

The North America non-invasive intracranial pressure monitoring device market dominated the global market and accounted for the largest revenue share of 45.1% in 2024. Each year, 2 million Americans are treated for TBI, with 56,000 deaths and 80,000 individuals requiring assistance due to TBI-related impairments. In addition, 5.3 million Americans live with TBI-related disabilities, costing over USD 56 billion annually in care and lost earnings. This high prevalence and the critical need for effective management of TBI complications, including elevated ICP, drive the demand for non-invasive intracranial pressure monitoring devices industry in North America.

The non-invasive intracranial pressure monitoring market in the U.S. led the North America market with the largest revenue share in 2024. In 2023, approximately 25,000 individuals in the U.S. were diagnosed with brain and nervous system cancers, with approximately 19,000 deaths. These cancers represent 1 in every 100 cancer diagnoses in the U.S. and are among the most common cancers in children and young adults.

Europe Non-Invasive Intracranial Pressure Monitoring Device Market Trends

The Europe non-invasive intracranial pressure monitoring device market held a substantial market share in 2024. In the European Union, brain injuries result in 1.5 million hospital admissions annually and 57,000 deaths. The incidence rate is 287 per 100,000 people, with a fatality rate of 15 per 100,000. Some countries, such as the UK, report significantly higher incidence rates, reaching 453 per 100,000, with 10.9% of these cases classified as moderate to severe. Around 165 million people in Europe are currently affected by brain disorders, and it is projected that 1 in 3 individuals will face a neurological or mental health condition at some stage in their life.

Asia Pacific Non-Invasive Intracranial Pressure Monitoring Device Market Trends

The Asia Pacific non-invasive intracranial pressure monitoring device market is expected to grow at the fastest CAGR of 6.2% over the forecast period. This is attributed to the presence of a large patient base in the emerging economies, such as India and China, along with rising healthcare expenditures in this region. Moreover, an increase in the number of clinical trials and high R&D investments by global market players, owing to low-cost services in the region, are high-impact drivers in the market. In addition, the increasing incidence of road accidents and neurological diseases is aiding the market growth in this region.

The non-invasive intracranial pressure monitoring device market in China dominated the Asia Pacific market with the largest revenue share in 2024. In China, TBI is a leading cause of injury and the fifth-leading cause of death among younger adults, with RTAs contributing to 61% of TBIs. In addition, the country has a growing elderly population with cognitive impairments, including 15.07 million individuals over 60 with dementia and 38.8 million with Mild Cognitive Impairment (MCI).

Key Non-invasive Intracranial Pressure Monitoring Devices Company Insights

Key companies in the global non-invasive intracranial pressure monitoring device industry include Medtronic, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, and RAUMEDIC AG, among others. These companies focus on innovation, strategic partnerships, and geographic expansion. They invest in R&D to improve device accuracy and usability, ensure compliance with regulatory standards, and offer affordable solutions. Clinical studies and training programs help increase adoption and expand into emerging markets, which drives growth and market share.

  • Medtronic operates in over 150 countries and offers a wide range of products across various medical fields, including cardiovascular, diabetes, neurological, and surgical solutions. Medtronic is known for its innovations and focuses on developing advanced medical devices, therapies, and services that address critical healthcare needs.

  • Integra LifeSciences Corporation is a medical technology company that develops, manufactures, and markets innovative solutions for patients and healthcare providers. It is headquartered in Princeton, New Jersey, and focuses on a wide range of medical areas, including neurosurgery, orthopedics, and wound care products. The company is known for its expertise in regenerative medicine and advanced surgical technologies.

Key Non-Invasive Intracranial Pressure Monitoring Device Companies

The following are the leading companies in the non-invasive intracranial pressure monitoring devices market. These companies collectively hold the largest market share and dictate industry trends.

Recent Developments

  • In February 2025, Children’s National Hospital partnered with a Swiss medical device company, Compremium AG, to co-develop non-invasive pressure monitoring technologies for pediatric patients. The collaboration focuses on diagnosing pressure-related conditions such as intracranial pressure and venous pressure, particularly in patients with congenital heart disease.

  • In July 2024, SanBio Co., Ltd. received conditional marketing approval in Japan for “AKUUGO suspension for intracranial implantation,” a groundbreaking treatment for chronic motor paralysis caused by Traumatic Brain Injury (TBI).

Non-invasive Intracranial Pressure Monitoring Devices Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 371.9 million

Revenue forecast in 2030

USD 478.1 million

Growth rate

CAGR of 5.2% from 2025 to 2035

Base year for estimation

2024

Historical data

2018 - 2023

Forecast period

2025 - 2035

Report updated

April 2025

Quantitative units

Revenue in USD million/billion and CAGR from 2025 to 2035

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, trends

Segments covered

Type, application, and region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait

Key companies profiled

Medtronic, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, RAUMEDIC AG, Vittamed, Gaeltec Devices Ltd., HeadSense Medical, NeuroDx Development, and Sophysa

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Non-invasive Intracranial Pressure Monitoring Devices Market Report Segmentation

Type Outlook (Revenue, USD Million; 2018 - 2035)

    • Transcranial Doppler Ultrasonography 

    • Tympanic Membrane Displacement (TMD)

    • Optic Nerve Sheath Diameter

    • MRI/CT

    • Fundoscopy (papilledema)

  • Application Outlook (Revenue, USD Million; 2018 - 2035)

    • Traumatic Brain Injury

    • Intracerebral Hemorrhage

    • Meningitis

    • Subarachnoid Hemorrhage

    • Others

  • Regional Outlook (Revenue, USD Million; 2018 - 2035)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Related Reports

Table of Content

List Tables Figures

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email